122 related articles for article (PubMed ID: 15956646)
1. Divide and conquer: new generation of drugs targets mitosis.
Garber K
J Natl Cancer Inst; 2005 Jun; 97(12):874-6. PubMed ID: 15956646
[No Abstract] [Full Text] [Related]
2. Aurora kinases dawn as cancer drug targets.
Sausville EA
Nat Med; 2004 Mar; 10(3):234-5. PubMed ID: 14991042
[No Abstract] [Full Text] [Related]
3. Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and others.
Warner SL; Gray PJ; Von Hoff DD
Semin Oncol; 2006 Aug; 33(4):436-48. PubMed ID: 16890798
[TBL] [Abstract][Full Text] [Related]
4. Polo and Aurora kinases: lessons derived from chemical biology.
Taylor S; Peters JM
Curr Opin Cell Biol; 2008 Feb; 20(1):77-84. PubMed ID: 18249108
[TBL] [Abstract][Full Text] [Related]
5. PLK1 inhibitors: setting the mitotic death trap.
Plyte S; Musacchio A
Curr Biol; 2007 Apr; 17(8):R280-3. PubMed ID: 17437704
[TBL] [Abstract][Full Text] [Related]
6. [The serine/threonine kinases that control cell cycle progression as therapeutic targets].
Diallo A; Prigent C
Bull Cancer; 2011 Nov; 98(11):1335-45. PubMed ID: 22020767
[TBL] [Abstract][Full Text] [Related]
7. Discovery and development of aurora kinase inhibitors as anticancer agents.
Pollard JR; Mortimore M
J Med Chem; 2009 May; 52(9):2629-51. PubMed ID: 19320489
[No Abstract] [Full Text] [Related]
8. Aurora kinases: new targets for cancer therapy.
Carvajal RD; Tse A; Schwartz GK
Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803
[TBL] [Abstract][Full Text] [Related]
9. Progress in the development of selective inhibitors of Aurora kinases.
Mortlock A; Keen NJ; Jung FH; Heron NM; Foote KM; Wilkinson R; Green S
Curr Top Med Chem; 2005; 5(2):199-213. PubMed ID: 15853647
[TBL] [Abstract][Full Text] [Related]
10. Role of mitogen-activated protein kinase in taxol-induced apoptosis in human leukemic U937 cells.
Lieu CH; Liu CC; Yu TH; Chen KD; Chang YN; Lai YK
Cell Growth Differ; 1998 Sep; 9(9):767-76. PubMed ID: 9751120
[TBL] [Abstract][Full Text] [Related]
11. Aurora A: target invalidated?
Cochran AG
Chem Biol; 2008 Jun; 15(6):525-6. PubMed ID: 18559262
[TBL] [Abstract][Full Text] [Related]
12. Aurora A and B kinases as targets for cancer: will they be selective for tumors?
Matthews N; Visintin C; Hartzoulakis B; Jarvis A; Selwood DL
Expert Rev Anticancer Ther; 2006 Jan; 6(1):109-20. PubMed ID: 16375648
[TBL] [Abstract][Full Text] [Related]
13. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint.
Hauf S; Cole RW; LaTerra S; Zimmer C; Schnapp G; Walter R; Heckel A; van Meel J; Rieder CL; Peters JM
J Cell Biol; 2003 Apr; 161(2):281-94. PubMed ID: 12707311
[TBL] [Abstract][Full Text] [Related]
14. Target validation and biomarker identification in oncology : the example of aurora kinases.
Colombo R; Moll J
Mol Diagn Ther; 2008; 12(2):71-6. PubMed ID: 18422371
[TBL] [Abstract][Full Text] [Related]
15. Development and biological evaluation of potent and specific inhibitors of mitotic Kinesin Eg5.
Gartner M; Sunder-Plassmann N; Seiler J; Utz M; Vernos I; Surrey T; Giannis A
Chembiochem; 2005 Jul; 6(7):1173-7. PubMed ID: 15912555
[No Abstract] [Full Text] [Related]
16. Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor.
Straight AF; Cheung A; Limouze J; Chen I; Westwood NJ; Sellers JR; Mitchison TJ
Science; 2003 Mar; 299(5613):1743-7. PubMed ID: 12637748
[TBL] [Abstract][Full Text] [Related]
17. American Association of Cancer Research--95th annual meeting. Kinases. 27-31 March, 2004, Orlando, FL, USA.
Kibble A; Davies J
IDrugs; 2004 May; 7(5):411-3. PubMed ID: 15154094
[No Abstract] [Full Text] [Related]
18. The use of high-content screening for the discovery and characterization of compounds that modulate mitotic index and cell cycle progression by differing mechanisms of action.
Barabasz A; Foley B; Otto JC; Scott A; Rice J
Assay Drug Dev Technol; 2006 Apr; 4(2):153-63. PubMed ID: 16712419
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of Aurora kinase inhibitors in cancer.
Naruganahalli KS; Lakshmanan M; Dastidar SG; Ray A
Curr Opin Investig Drugs; 2006 Dec; 7(12):1044-51. PubMed ID: 17209521
[TBL] [Abstract][Full Text] [Related]
20. Aurora kinases and their inhibitors: more than one target and one drug.
Carpinelli P; Moll J
Adv Exp Med Biol; 2008; 610():54-73. PubMed ID: 18593015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
